The Effects of Sedatives on Tobacco Use Disorder

Brief Summary

This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.

Intervention / Treatment

  • Drug: midazolam intravenous infusion
  • Drug: placebo intravenous infusion
  • Drug: Ketamine Intravenous Infusion

Condition or Disease

  • Tobacco Use Disorder

Phase

Study Design

Study type: Interventional
Status: Recruiting
Study results: No Results Available
Age: 18 Years to 55 Years   (Adult)
Enrollment: 20 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Jun 01, 2019
Primary Completion: May 31, 2021
Completion Date: May 31, 2021
Study First Posted: Jan 23, 2019
Results First Posted: Aug 31, 2020
Last Updated: Jul 21, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 55

This clinical trial is recruiting

Are you interested in participating in this trial or others? We'd love to help.

More Details

NCT Number: NCT03813121
Acronym: SED-TUD
Other IDs: 229077
Study URL: https://ClinicalTrials.gov/show/NCT03813121
Last updated: Jan 27, 2021